Featured Articles

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,919 million.  Advent’s…
Read More...

Phoenix Molecular Designs (PhoenixMD) announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026…
Read More...

Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to…
Read More...

Germfree has released bioGO this week in New York at INTERPHEX. The biomanufacturing platform represents a completely new approach to quick and flexible production space. The company…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved Tagrisso (osimertinib) for the 1st-line treatment of patients with metastatic non-small cell…
Read More...

Sempre Health announced it's collaborating on a pilot program with Novo Nordisk to add diabetes medications to the Sempre Health affordability & engagement solution. Unlike…
Read More...

ProBioGen AG announced that it has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, Inc., a privately held immunology company,…
Read More...

During the past several years, many strains of bacteria have become resistant to existing antibiotics, and very few new drugs have been added to the antibiotic arsenal. To help…
Read More...

GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and…
Read More...

Merck announced that the company is beginning two Phase 3 studies of PCV-15 (V114), its investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease. The…
Read More...

Shire plc announces that it has entered into a definitive agreement with Servier S.A.S. to sell its Oncology business for $2.4 billion. Shire's Oncology business includes in-market…
Read More...

Sobi has received approval from Health Canada for a reduced dosing frequency for Orfadin (nitisinone). Orfadin is approved in combination with dietary restriction of tyrosine and…
Read More...

Almac Group announced that it has expanded its US commercial packaging capabilities at its Audubon, PA facility. Addressing increased client demand of developing and bringing more…
Read More...

BioAscent Discovery Limited has announced the launch of a comprehensive suite of integrated drug discovery services with immediate effect. Dr Phil Jones will be joining as Chief…
Read More...

MilliporeSigma announced a partnership with Oxford University's Jenner Institute to develop more robust and scalable vaccine manufacturing processes. This partnership, as well as plans…
Read More...

GSK and Orchard Therapeutics announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard,…
Read More...

Ionis Pharmaceuticals announced that it has licensed IONIS-AZ6-2.5-LRx, or AZD2693, to AstraZeneca following advancement of the drug into development. IONIS-AZ6-2.5-LRx is designed to…
Read More...

Lonza is opening the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies – the next…
Read More...

Halo Pharma, a rapidly growing contract development and manufacturing organization (CDMO), offers more than 30 years’ direct experience in the production of topical drug products – from…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Afinitor DISPERZ (everolimus tablets for oral suspension), for the adjunctive treatment of adult and…
Read More...